Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

MNMD Company Profile and Key Details

NASDAQ : MNMD

Mind Medicine (MindMed) Inc.

$5.80
0.14+2.47%
At Close 4:00 PM
63.25
BESG ScoreESG Rating
ProfileKey StatsAnalyst RatingsOwnershipRatiosFinancialsDividend & splitsSentimentForecast

Price Chart

Stock Price Today

Mind Medicine (MindMed) Inc. (MNMD) stock surged +2.47%, trading at $5.80 on NASDAQ, up from the previous close of $5.66. The stock opened at $5.73, fluctuating between $5.72 and $5.94 in the recent session.

Stock Snapshot

5.66
Prev. Close
5.73
Open
437.14M
Market Cap
75.37M
Number of Shares
5.72
Day Low
5.94
Day High
-3.77
P/E Ratio
96.47%
Free Float in %
-1.54
EPS (TTM)
1.94
Book Value
-1.58
Cash Flow per Share
912.7K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date
Apr 21, 2025Apr 21, 2025
Apr 15, 2025Apr 15, 2025
Mar 6, 2025Mar 6, 2025
Jan 30, 2025Jan 30, 2025
Jan 13, 2025Jan 13, 2025
Dec 16, 2024Dec 16, 2024
Nov 7, 2024Nov 7, 2024
Oct 17, 2024Oct 17, 2024
Aug 13, 2024Aug 13, 2024
Aug 12, 2024Aug 12, 2024
Jun 28, 2024Jun 28, 2024
Jun 20, 2024Jun 20, 2024
Jun 11, 2024Jun 11, 2024
May 8, 2024May 8, 2024
Apr 1, 2024Apr 1, 2024
Mar 11, 2024Mar 11, 2024
Mar 7, 2024Mar 7, 2024
Mar 7, 2024Mar 7, 2024
Feb 28, 2024Feb 28, 2024
Jan 8, 2024Jan 8, 2024
Dec 14, 2023Dec 14, 2023
Nov 2, 2023Nov 2, 2023
Sep 15, 2023Sep 15, 2023
Sep 15, 2023Sep 15, 2023
Aug 14, 2023Aug 14, 2023
Aug 14, 2023Aug 14, 2023
Aug 3, 2023Aug 3, 2023
Jul 25, 2023Jul 25, 2023
Jun 27, 2023Jun 27, 2023
Jun 20, 2023Jun 20, 2023
Jun 16, 2023Jun 16, 2023
Jun 15, 2023Jun 15, 2023
May 24, 2023May 24, 2023
May 17, 2023May 17, 2023
May 4, 2023May 4, 2023
Apr 18, 2023Apr 18, 2023
Apr 18, 2023Apr 18, 2023
Apr 14, 2023Apr 14, 2023
Mar 13, 2023Mar 13, 2023
Mar 9, 2023Mar 9, 2023
Jan 9, 2023Jan 9, 2023
Nov 10, 2022Nov 10, 2022
Sep 29, 2022Sep 29, 2022
Sep 14, 2022Sep 14, 2022
Aug 26, 2022Aug 26, 2022
Aug 11, 2022Aug 11, 2022
Jul 21, 2022Jul 21, 2022
Jun 30, 2022Jun 30, 2022
Jun 2, 2022Jun 2, 2022
May 23, 2022May 23, 2022
May 19, 2022May 19, 2022
May 16, 2022May 16, 2022
May 11, 2022May 11, 2022
Apr 26, 2022Apr 26, 2022
Mar 28, 2022Mar 28, 2022
Mar 25, 2022Mar 25, 2022
Feb 23, 2022Feb 23, 2022
Jan 25, 2022Jan 25, 2022
Jan 7, 2022Jan 7, 2022

Annual Report (10-k)

Filing DateAccepted Date
Mar 6, 2025Mar 6, 2025
Feb 28, 2024Feb 28, 2024
Mar 9, 2023Mar 9, 2023
Mar 28, 2022Mar 28, 2022

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 22, 20255.735.945.725.80921.4K
Apr 21, 20255.695.745.515.66712.92K
Apr 17, 20255.465.845.455.771.17M
Apr 16, 20255.585.705.365.46507.47K
Apr 15, 20255.535.855.455.60650.45K
Apr 14, 20255.685.855.385.551.02M
Apr 11, 20255.145.445.055.43603.15K
Apr 10, 20255.515.514.995.141.08M
Apr 09, 20254.735.794.705.682.08M
Apr 08, 20255.655.754.774.891.61M
Apr 07, 20255.005.554.835.431.95M
Apr 04, 20255.245.554.935.432.65M
Apr 03, 20255.625.755.445.551.44M
Apr 02, 20255.406.065.335.971.51M
Apr 01, 20255.845.845.485.541.51M
Mar 31, 20256.006.075.665.851.54M
Mar 28, 20256.386.496.106.191.09M
Mar 27, 20256.516.586.276.431.29M
Mar 26, 20256.806.836.426.581.38M
Mar 25, 20256.946.976.676.781.04M

Contact Details

Vancouver, BC V6E 2E9

Canada

Website: https://www.mindmed.coContact: 650 208 2454

About Company

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Company Information

Employees74
Beta2.39
Sales or Revenue$0.00
5Y Sales Change%0%
Fiscal Year EndsDecember
SectorHealthcare
IndustryBiotechnology

Stock Peers

ARGX
4.17+0.70%
argenx SE$599.87REGN
24+4.27%
Regeneron Pharmaceuticals, Inc.$585.49VRTX
12.95+2.71%
Vertex Pharmaceuticals Incorporated$490.47KRTX
0.09+0.03%
Karuna Therapeutics, Inc.$329.83MDGL
7.7+2.61%
Madrigal Pharmaceuticals, Inc.$302.72UTHR
8.57+3.01%
United Therapeutics Corporation$292.82ALNY
4+1.72%
Alnylam Pharmaceuticals, Inc.$236.75SGEN
-0.16-0.07%
Seagen Inc.$228.74BGNE
0.9+0.49%
BeiGene, Ltd.$184.71RETA
0.04+0.02%
Reata Pharmaceuticals, Inc.$172.36

Frequently Asked Questions

What is the current Mind Medicine (MindMed) Inc. (MNMD) stock price?
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) stock price is $5.80 in the last trading session. During the trading session, MNMD stock reached the peak price of $5.94 while $5.72 was the lowest point it dropped to. The percentage change in MNMD stock occurred in the recent session was 2.47% while the dollar amount for the price change in MNMD stock was $0.14.
MNMD's industry and sector of operation?
The NASDAQ listed MNMD is part of Biotechnology industry that operates in the broader Healthcare sector. Mind Medicine (MindMed) Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of MNMD?
Ms. Wong Hu J.D.
Chief Legal Officer & Corporation Sec.
Mr. Leonard Latchman
Co-founder
Dr. Daniel Rollings Karlin M.A., M.D.
Chief Medical Officer
Ms. Carrie F. Liao C.P.A., CGMA
Vice President & Chief Accounting Officer
Mr. Schond L. Greenway
Chief Financial Officer
Dr. Miriam Halperin Wernli Ph.D.
Executive Pres
Mr. Robert Barrow
Chief Executive Officer & Director
Ms. Carrie F. Liao CPA, CGMA
Vice President & Chief Accounting Officer
Dr. Francois P. Lilienthal M.B.A., M.D.
Chief Commercial Officer
Mr. Mark R. Sullivan J.D.
Chief Legal Officer & Corporation Sec.
Dr. Scott M. Freeman M.D.
Co-Founder & Clinical Advisor
Mr. Maxim Jacobs C.F.A.
Vice President of Investor Relations
How MNMD did perform over past 52-week?
MNMD's closing price is 23.4% higher than its 52-week low of $4.70 where as its distance from 52-week high of $10.44 is -44.42%.
How many employees does MNMD have?
Number of MNMD employees currently stands at 74.
Link for MNMD official website?
Official Website of MNMD is: https://www.mindmed.co
How do I contact MNMD?
MNMD could be contacted at phone 650 208 2454 and can also be accessed through its website. MNMD operates from 1055 West Hastings Street, Vancouver, BC V6E 2E9, Canada.
How many shares of MNMD are traded daily?
MNMD stock volume for the day was 912.7K shares. The average number of MNMD shares traded daily for last 3 months was 1.94M.
What is the market cap of MNMD currently?
The market value of MNMD currently stands at $437.14M with its latest stock price at $5.80 and 75.37M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings Calendar
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph